R1 Therapeutics is based in Redwood City, California. It has raised $78M in total funding. Latest round: Series A.
R1 Therapeutics is based in Redwood City, California. R1 Therapeutics has raised $78M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2026. The round record for R1 Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Abingworth, F-Prime Capital, DaVita Venture Group, Curie.Bio, SymBiosis, U.S. Renal Care. 6 distinct backers are named across the disclosed rounds.
Round data for R1 Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Redwood City and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026